Renowned medical experts share their insights into new data presented at ESMO 2024
Module 3: Combining locoregional and systemic treatments in intermediate HCC
Module 4: Treatment strategies for patients ineligible for IO or those with progression on IO
Experts join us at ESMO 2026 to share their insights on new data on GI, liver, lung, breast and GU cancers